Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Non-cash Items (2016 - 2025)

Perspective Therapeutics' Non-cash Items history spans 14 years, with the latest figure at $4.0 million for Q4 2024.

  • For Q4 2024, Non-cash Items fell 99.94% year-over-year to $4.0 million; the TTM value through Dec 2024 reached $4.0 million, down 99.94%, while the annual FY2024 figure was $4.0 million, 99.94% down from the prior year.
  • Non-cash Items for Q4 2024 was $4.0 million at Perspective Therapeutics, down from $6.7 billion in the prior quarter.
  • Across five years, Non-cash Items topped out at $6.7 billion in Q4 2023 and bottomed at $2000.0 in Q2 2022.
  • The 5-year median for Non-cash Items is $3.8 million (2020), against an average of $482.2 million.
  • The largest annual shift saw Non-cash Items surged 685200.0% in 2023 before it plummeted 99.94% in 2024.
  • A 5-year view of Non-cash Items shows it stood at $3.8 million in 2020, then increased by 11.33% to $4.2 million in 2021, then skyrocketed by 41.58% to $6.0 million in 2022, then surged by 111956.3% to $6.7 billion in 2023, then tumbled by 99.94% to $4.0 million in 2024.
  • Per Business Quant, the three most recent readings for CATX's Non-cash Items are $4.0 million (Q4 2024), $6.7 billion (Q4 2023), and $2.3 million (Q3 2023).